None listed
Conditions
Brief summary
The purpose of this study was to see if there is a role for intravenous (IV) fluids in improving patient outcomes during routine colonoscopies. Who is it for? You may be eligible for this study if you are aged 18 to 80, and are scheduled for a colonoscopy. Study details Participants in this study were randomised by chance (like flipping a coin) into two groups. One group received intravenous fluids through a needle in the arm while they have their colonoscopy. The other group did not receive the needle in the arm and had no fluids during the procedure. As part of this study, participants had additional blood tests (to see if they were adequately hydrated) as well as completed some questionnaires. It was believed this research will demonstrate there is no significant difference between the groups, which could reduce the unnecessary use of intravenous fluids during colonoscopy.
Interventions
The patients will be randomised to either receive or not receive IV crystalloid fluids during their routine colonoscopy. The intervention treatment in this study is the administration of IV fluids; therefore the intervention arm is recieving fluids. The fluids will be administered by anaesthetic staff through an IV cannula (the IV cannula will be placed in the patient regardless of whether they participate in the trial or not).
All participants who agree to be a part of the study will be ask
The patients will be randomised to either receive or not receive IV crystalloid fluids during their routine colonoscopy. The intervention treatment in this study is the administration of IV fluids; therefore the intervention arm is recieving fluids. The fluids will be administered by anaesthetic staff through an IV cannula (the IV cannula will be placed in the patient regardless of whether they participate in the trial or not). All participants who agree to be a part of the study will be asked a series of questions before and after the procedure to gauge their tolerance and outcomes. All participants will also have a blood sample analysed before and after their procedure, and will be appropriately consented as to the risks involved. All participants in this study will be recieving a form of procedural anaesthesia, a black bag will be placed over the intra-venous fluid set up as well to ensure blinding. The treatment is not personalized nor is it tailored to the individuals, and will be administered according to their randomization. There will be no specific monitoring of adherence, withdrawal after randomization has been recorded.
Sponsors
Timothy Ganguly
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Blinded (masking used) (Subject)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
Yes
Inclusion criteria
Age>18 & <80 Non-pregnant ASA I-III No documented evidence of significant renal impairment (creatinine clearance level) Routine endoscopies and colonoscopies on outpatients
Exclusion criteria
age <18 & >80 pregnant renal failure, creatinine clearance <60 ASA IV Patients unable to consent Inpatients, patients actively bleeding or with acute illness to be excluded
Outcome results
None listed